1. Home
  2. PUBM vs MRVI Comparison

PUBM vs MRVI Comparison

Compare PUBM & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PUBM
  • MRVI
  • Stock Information
  • Founded
  • PUBM 2006
  • MRVI 2014
  • Country
  • PUBM United States
  • MRVI United States
  • Employees
  • PUBM N/A
  • MRVI N/A
  • Industry
  • PUBM Computer Software: Prepackaged Software
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • PUBM Technology
  • MRVI Health Care
  • Exchange
  • PUBM Nasdaq
  • MRVI Nasdaq
  • Market Cap
  • PUBM 576.6M
  • MRVI 312.4M
  • IPO Year
  • PUBM 2020
  • MRVI 2020
  • Fundamental
  • Price
  • PUBM $12.80
  • MRVI $2.67
  • Analyst Decision
  • PUBM Buy
  • MRVI Hold
  • Analyst Count
  • PUBM 11
  • MRVI 10
  • Target Price
  • PUBM $22.60
  • MRVI $6.84
  • AVG Volume (30 Days)
  • PUBM 557.4K
  • MRVI 1.9M
  • Earning Date
  • PUBM 08-07-2025
  • MRVI 08-06-2025
  • Dividend Yield
  • PUBM N/A
  • MRVI N/A
  • EPS Growth
  • PUBM N/A
  • MRVI N/A
  • EPS
  • PUBM 0.10
  • MRVI N/A
  • Revenue
  • PUBM $288,380,000.00
  • MRVI $241,856,000.00
  • Revenue This Year
  • PUBM $2.70
  • MRVI N/A
  • Revenue Next Year
  • PUBM $10.37
  • MRVI $10.62
  • P/E Ratio
  • PUBM $129.81
  • MRVI N/A
  • Revenue Growth
  • PUBM 3.62
  • MRVI N/A
  • 52 Week Low
  • PUBM $7.46
  • MRVI $1.67
  • 52 Week High
  • PUBM $22.99
  • MRVI $10.03
  • Technical
  • Relative Strength Index (RSI)
  • PUBM 69.05
  • MRVI 67.02
  • Support Level
  • PUBM $11.09
  • MRVI $2.32
  • Resistance Level
  • PUBM $12.97
  • MRVI $2.72
  • Average True Range (ATR)
  • PUBM 0.43
  • MRVI 0.15
  • MACD
  • PUBM 0.13
  • MRVI 0.05
  • Stochastic Oscillator
  • PUBM 89.47
  • MRVI 92.36

About PUBM PubMatic Inc.

PubMatic Inc is a supply-side platform provider in the digital advertising technology market. These platforms help publishers, which supply digital ad inventory, manage their inventory, selling a high percentage of their inventory (increase the ad fill rate) and maximizing revenue per ad sold (optimize yield). The company generates revenue mainly by taking a piece of the ad sales that it enables. Buyers on the platform include intermediary buyers, such as demand-side platforms, or advertisers and ad agencies directly. Geographically, the company generates the majority of its revenue from the United States, followed by EMEA and APAC.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: